Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

*Acorus calamus* has many medicinal benefits but needs more safety research.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Type I interferons play a key role in the development of various skin diseases.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Some chemicals absorbed through the skin can cause serious health problems.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.